Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104645) titled 'a study to compare effects and side effects of two drugs commonly used for alopecia areata known as oral mini pulse and a newer drug tofacitinib' on Feb. 24.

Study Type: Interventional

Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Permuted block randomization, variable Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Outcome Assessor Blinded

Primary Sponsor: NA

Condition: Health Condition 1: L639- Alopecia areata, unspecified

Intervention: Intervention1: Tablet tofacitinib: tablet tofacitinib 5mg twice...